Multivalent Bicyclic Peptides Are an Effective Antiviral Modality That Can Potently Inhibit SARS-CoV-2

Investigators described a third antiviral modality that combined the drug-like advantages of antibody and small molecule therapeutics to inhibit SARS-CoV-2 infection.